Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-study

Friederike Löffler1, Justus Christian Garlichs1, Kirsten Linhorst1

  • 1Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, Hannover 30625, Germany.

European Heart Journal Open
|November 12, 2025
PubMed

Insights

Secondary hyperparathyroidism (sHPT) affects 14.9% of adults with congenital heart disease (ACHD), particularly those with complex conditions. Factors like kidney function and vitamin D levels influence sHPT development in ACHD patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Secondary hyperparathyroidism (sHPT) is linked to adverse outcomes in non-congenital heart disease.
  • The prevalence and predictors of sHPT in adults with congenital heart disease (ACHD) are not well understood.

Purpose of the Study:

  • To determine the prevalence of sHPT in a large ACHD cohort.
  • To identify independent predictors of sHPT in ACHD patients, considering biventricular physiology.

Main Methods:

  • Cross-sectional, single-centre study of 754 ACHD patients.
  • Assessed sHPT prevalence and identified independent predictors using multivariate analysis.
  • Analyzed predictors in the entire cohort and specifically in those with biventricular physiology.

Main Results:

  • A high prevalence of sHPT (14.9%) was found in ACHD patients.
  • Higher sHPT rates were observed in patients with Eisenmenger syndrome/PAH-CHD, Ebstein's anomaly, Fontan palliation, and pulmonary atresia.
  • sHPT was more common in univentricular (29.6%) versus biventricular physiology (13.3%).
  • Independent predictors included glomerular filtration rate, 25-hydroxyvitamin D₃ levels, loop diuretic use, oxygen saturation, and liver stiffness.
  • Right ventricular free wall longitudinal strain, not left ventricular strain, was associated with sHPT in biventricular physiology.

Conclusions:

  • sHPT is prevalent across the ACHD spectrum.
  • sHPT is more common in patients with complex and severe ACHD, especially those with right heart involvement.
  • Predictors of sHPT in ACHD involve renal function, vitamin D status, medication use, oxygenation, and cardiac strain.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
4.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
452
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
206
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695